Antibodies News and Research

RSS

Persistent COVID-19 could drive virus evolution, new study suggests

Study reveals the prevalence of persistent SARS-CoV-2 infection in the UK, showing its potential role in viral evolution and the emergence of new variants, with implications for long-COVID and public health strategies.

22 Feb 2024

Aptamer and Neuro-Bio enter the second phase of Alzheimer’s test development

Aptamer Group plc, the developer of novel Optimer binders to enable innovation in the life sciences industry, announces the second phase of its on-going partnership with Neuro-Bio, an Oxfordshire-based biotechnology company with a therapeutic focus on neurodegenerative disease, to develop Optimer binders for a lateral flow test for the early diagnosis of Alzheimer’s disease

From Aptamer Group 22 Feb 2024

The correlation between adopting unhealthy dietary habits and migraine severity

A recent study aimed to study the correlation between migraine severity and adopting unhealthy dietary habits. It also sought to identify specific foods that could trigger particular subtypes of migraine.

22 Feb 2024

Scripps Research scientists develop an antibody that blocks lethal snake toxins

Scripps Research scientists have developed an antibody that can block the effects of lethal toxins in the venoms of a wide variety of snakes found throughout Africa, Asia and Australia.

21 Feb 2024

Study reveals high prevalence of persistent COVID-19 infections in general population

A new study led by the University of Oxford has found that a high proportion of SARS-CoV-2 infections in the general population lead to persistent infections lasting a month or more.

21 Feb 2024

MIP Discovery closes £7M Series A financing to drive commercialization in cell and gene therapy space

Company’s synthetic affinity reagents are antibody alternatives designed to advance the speed, safety, and efficiency of manufacturing at scale, making advanced therapies more accessible to patients.

From MIP Discovery 20 Feb 2024

Novel monoclonal antibody shows promise in targeting HER2-positive breast cancer cells

In a step forward for breast cancer treatment, researchers at Tohoku University have developed a novel monoclonal antibody which specifically targets a certain type of breast cancer cell.

19 Feb 2024

Study reveals seasonal MERS-CoV peaks in Kenyan camels and potential human transmission

Researchers found biphasic peaks of MERS-CoV in dromedaries in Kenya, with evidence of serologic exposure among slaughterhouse workers, highlighting potential human transmission risks.

18 Feb 2024

Genetic mechanism shields bacterial communities from viral threats

Like humans struggling to get through the COVID-19 pandemic, bacterial cells need social distancing to thwart viruses.

16 Feb 2024

Innovative immunotherapy targets rare melanoma subtypes

Scientists at the UCLA Health Jonsson Comprehensive Cancer Center have built and demonstrated the potential efficacy of a new chimeric antigen receptor (CAR) T-cell-based immunotherapy specifically designed to treat patients with cutaneous and rare subtypes of melanoma.

16 Feb 2024

City of Hope cures oldest person of blood cancer and achieves HIV remission

City of Hope, one of the largest cancer research and treatment organizations in the United States, treated the oldest person to be cured of a blood cancer and then achieve remission for HIV after receiving a blood stem cell transplant from a donor with a rare genetic mutation.

15 Feb 2024

Novel splicing mechanism for short introns discovered

Researchers confirm that the established pre-mRNA splicing mechanism that appears in textbooks cannot work in a subset of human short introns: A novel SAP30BP–RBM17 complex-dependent splicing has been uncovered.

15 Feb 2024

Maternal mRNA COVID-19 vaccination shields infants for six months

Women who receive an mRNA-based COVID-19 vaccination or booster during pregnancy can provide their infants with strong protection against symptomatic COVID-19 infection for at least six months after birth, according to a study from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

15 Feb 2024

Managing migraines and menopausal symptoms to reduce cardiovascular risks in middle-aged women

14 Feb 2024

Advanced melanoma survival rates improve significantly from 2013 to 2019, Dutch study finds

The change in overall survival (OS) among advanced melanoma patients diagnosed between 2013 and 2021.

14 Feb 2024

Home-administered COVID-19 rapid antigen tests show comparable accuracy to clinician-performed tests

In a study involving nearly 1,000 patients seen at the Baltimore Convention Center Field Hospital (BCCFH) during a five-month period in 2022 -; researchers at Johns Hopkins Medicine, the University of Maryland School of Medicine and five other collaborators report that a rapid antigen test (RAT) for detecting SARS-CoV-2, the virus that causes COVID-19, can be used at home with accuracy comparable to the same test being administered by a health care professional.

13 Feb 2024

Hand-held biosensor detects breast cancer biomarkers from saliva

Breast cancer is on the rise, but new tools for early detection could save lives.

13 Feb 2024

Olive oil's secret weapon against Alzheimer's: phenolic compounds

A comprehensive review in the International Journal of Molecular Sciences highlights the potential of extra-virgin olive oil and its phenolic compounds in preventing and treating Alzheimer's disease through various mechanisms, including reducing amyloid-beta accumulation and neuroinflammation.

12 Feb 2024

Promising new CMV vaccine shows stronger immune response

An experimental mRNA vaccine against human cytomegalovirus (CMV), a common virus that can infect babies during pregnancy, elicited some of the most promising immune responses to date of any CMV vaccine candidate, according to a study by Weill Cornell Medicine investigators.

12 Feb 2024

CDC releases new syphilis testing guidelines to combat rising cases

The CDC's new guidelines in the Morbidity and Mortality Weekly Report outline comprehensive testing protocols for syphilis diagnosis, emphasizing the combined use of nontreponemal and treponemal tests to improve detection and management of the disease in the U.S.

11 Feb 2024

Antibodies News and Research

Persistent COVID-19 could drive virus evolution, new study suggests

Aptamer and Neuro-Bio enter the second phase of Alzheimer’s test development

The correlation between adopting unhealthy dietary habits and migraine severity

Scripps Research scientists develop an antibody that blocks lethal snake toxins

Study reveals high prevalence of persistent COVID-19 infections in general population

MIP Discovery closes £7M Series A financing to drive commercialization in cell and gene therapy space

Novel monoclonal antibody shows promise in targeting HER2-positive breast cancer cells

Study reveals seasonal MERS-CoV peaks in Kenyan camels and potential human transmission

Genetic mechanism shields bacterial communities from viral threats

Innovative immunotherapy targets rare melanoma subtypes

City of Hope cures oldest person of blood cancer and achieves HIV remission

Novel splicing mechanism for short introns discovered

Maternal mRNA COVID-19 vaccination shields infants for six months

Managing migraines and menopausal symptoms to reduce cardiovascular risks in middle-aged women

Advanced melanoma survival rates improve significantly from 2013 to 2019, Dutch study finds

Home-administered COVID-19 rapid antigen tests show comparable accuracy to clinician-performed tests

Hand-held biosensor detects breast cancer biomarkers from saliva

Olive oil's secret weapon against Alzheimer's: phenolic compounds

Promising new CMV vaccine shows stronger immune response

CDC releases new syphilis testing guidelines to combat rising cases

Immunology eBook

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News